mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.03 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.04 |